Literature DB >> 16183393

Critical assessment of how to study addiction and its treatment: human and non-human animal models.

Charles P O'Brien1, Eliot L Gardner.   

Abstract

Laboratory models, both animal and human, have made enormous contributions to our understanding of addiction. For addictive disorders, animal models have the great advantage of possessing both face validity and a significant degree of predictive validity, already demonstrated. Another important advantage to this field is the ability of reciprocal interplay between preclinical and clinical experiments. These models have made important contributions to the development of medications to treat addictive disorders and will likely result in even more advances in the future. Human laboratory models have gone beyond data obtained from patient histories and enabled investigators to make direct observations of human drug self-administration and test the effects of putative medications on this behavior. This review examines in detail some animal and human models that have led not only to important theories of addiction mechanisms but also to medications shown to be effective in the clinic.

Entities:  

Mesh:

Year:  2005        PMID: 16183393     DOI: 10.1016/j.pharmthera.2005.06.018

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  83 in total

1.  Dissociable role of tumor necrosis factor alpha gene deletion in methamphetamine self-administration and cue-induced relapsing behavior in mice.

Authors:  Yijin Yan; Atsumi Nitta; Takenao Koseki; Kiyofumi Yamada; Toshitaka Nabeshima
Journal:  Psychopharmacology (Berl)       Date:  2011-12-14       Impact factor: 4.530

2.  D-Serine facilitates the effectiveness of extinction to reduce drug-primed reinstatement of cocaine-induced conditioned place preference.

Authors:  Sherri Hammond; Claire M Seymour; Ashley Burger; John J Wagner
Journal:  Neuropharmacology       Date:  2012-06-20       Impact factor: 5.250

Review 3.  Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure.

Authors:  David H Epstein; Kenzie L Preston; Jane Stewart; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2006-09-22       Impact factor: 4.530

Review 4.  Translational and reverse translational research on the role of stress in drug craving and relapse.

Authors:  Rajita Sinha; Yavin Shaham; Markus Heilig
Journal:  Psychopharmacology (Berl)       Date:  2011-04-15       Impact factor: 4.530

5.  Prelimbic cortex and ventral tegmental area modulate synaptic plasticity differentially in nucleus accumbens during cocaine-reinstated drug seeking.

Authors:  Hao-wei Shen; Cassandra D Gipson; Martijn Huits; Peter W Kalivas
Journal:  Neuropsychopharmacology       Date:  2013-11-15       Impact factor: 7.853

6.  N-acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking.

Authors:  Wenhua Zhou; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2007-08-24       Impact factor: 13.382

Review 7.  The debate over dopamine's role in reward: the case for incentive salience.

Authors:  Kent C Berridge
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

8.  Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice.

Authors:  James P Kesby; David T Hubbard; Athina Markou; Svetlana Semenova
Journal:  Addict Biol       Date:  2012-12-18       Impact factor: 4.280

9.  Operant sensation seeking engages similar neural substrates to operant drug seeking in C57 mice.

Authors:  Christopher M Olsen; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2009-01-14       Impact factor: 7.853

10.  Prevalence of problem and pathological gambling in Parkinson's disease.

Authors:  David Crockford; Jeremy Quickfall; Shawn Currie; Sarah Furtado; Oksana Suchowersky; Nady El-Guebaly
Journal:  J Gambl Stud       Date:  2008-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.